Biomedical Systems (Maryland Heights, MO) has introduced an ambulatory ECG monitoring system that can record and wirelessly transmit heartbeat data for up to 30 days. The device provides immediate online access of all transmitted ECG data.
Designed for the diagnosis and management of atrial fibrillation and other cardiac arrhythmias, the TruVue ECG system uses cellular communication to transmit recordings of heartbeat data to secure servers operated by the company. Incoming data is analyzed to detect changes in morphology, rate, or rhythm, as well as patient-triggered alerts when symptoms are experienced.
The company employs certified cardiac technicians to validate the findings from the technology. The technicians post real-time reports and notify physicians based on cardiac events or notification criteria.
“With TruVue, we provide physicians with the unique ability to review every heartbeat for up to 30 days—combining both algorithm-triggered ECG-recordings and episodes recorded by patients–and immediately access information online without working through support staff,” Jim Ott, Biomedical Systems’ cardiology division president said in a statement.
The technology has received 510(k) clearance from the FDA as well as the CE Mark.